Larimar Therapeutics, Inc.
LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | 6.6Research and development, Q3 FY2023, three months to 2023-09-30$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 10.6Research and development, Q4 FY2023, three months to 2023-12-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0000950170-25-043925. Derived: 12-month figure less the 9-month figure.Report this figure | 12.9Research and development, Q1 FY2024, three months to 2024-03-31$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | 19.7Research and development, Q2 FY2024, three months to 2024-06-30$19.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 13.9Research and development, Q3 FY2024, three months to 2024-09-30$13.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 26.7Research and development, Q4 FY2024, three months to 2024-12-31$26.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | 26.6Research and development, Q1 FY2025, three months to 2025-03-31$26.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 23.4Research and development, Q2 FY2025, three months to 2025-06-30$23.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 44.9Research and development, Q3 FY2025, three months to 2025-09-30$44.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 59.4Research and development, Q4 FY2025, three months to 2025-12-31$59.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | 25.0Research and development, Q1 FY2026, three months to 2026-03-31$25.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 28.0Research and development, Q2 FY2026, three months to 2026-06-30$28.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Operating income | $m | (10.3)Operating income, Q3 FY2023, three months to 2023-09-30−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | (14.2)Operating income, Q4 FY2023, three months to 2023-12-31−$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043925. Derived: 12-month figure less the 9-month figure.Report this figure | (16.7)Operating income, Q1 FY2024, three months to 2024-03-31−$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | (24.6)Operating income, Q2 FY2024, three months to 2024-06-30−$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | (18.3)Operating income, Q3 FY2024, three months to 2024-09-30−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | (31.3)Operating income, Q4 FY2024, three months to 2024-12-31−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | (31.2)Operating income, Q1 FY2025, three months to 2025-03-31−$31.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | (27.8)Operating income, Q2 FY2025, three months to 2025-06-30−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | (49.5)Operating income, Q3 FY2025, three months to 2025-09-30−$49.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | (64.0)Operating income, Q4 FY2025, three months to 2025-12-31−$64.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | (31.1)Operating income, Q1 FY2026, three months to 2026-03-31−$31.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | (34.4)Operating income, Q2 FY2026, three months to 2026-06-30−$34.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | 0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | 0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported |
| Net income | $m | (9.1)Net income, Q3 FY2023, three months to 2023-09-30−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | (13.0)Net income, Q4 FY2023, three months to 2023-12-31−$13.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043925. Derived: 12-month figure less the 9-month figure.Report this figure | (14.7)Net income, Q1 FY2024, three months to 2024-03-31−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | (21.6)Net income, Q2 FY2024, three months to 2024-06-30−$21.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | (15.5)Net income, Q3 FY2024, three months to 2024-09-30−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | (28.8)Net income, Q4 FY2024, three months to 2024-12-31−$28.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | (29.3)Net income, Q1 FY2025, three months to 2025-03-31−$29.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | (26.2)Net income, Q2 FY2025, three months to 2025-06-30−$26.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | (47.7)Net income, Q3 FY2025, three months to 2025-09-30−$47.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | (62.5)Net income, Q4 FY2025, three months to 2025-12-31−$62.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | (29.6)Net income, Q1 FY2026, three months to 2026-03-31−$29.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | (32.8)Net income, Q2 FY2026, three months to 2026-06-30−$32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Diluted EPS | $ per share | (0.21)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | not reported | (0.27)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | (0.34)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | (0.24)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | not reported | (0.46)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | (0.41)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | (0.61)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | not reported | not reported | not reported |
| Basic EPS | $ per share | (0.21)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | not reported | (0.27)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | (0.34)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | (0.24)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | not reported | (0.46)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | (0.41)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | (0.61)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | not reported | not reported | not reported |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 38.7Cash and equivalents, Q3 FY2023, at 2023-09-30$38.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0000950170-23-063517.Report this figure | 26.7Cash and equivalents, FY2023, at 2023-12-31$26.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0000950170-25-043925.Report this figure | 110Cash and equivalents, Q1 FY2024, at 2024-03-31$110.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-056965.Report this figure | 32.3Cash and equivalents, Q2 FY2024, at 2024-06-30$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093733.Report this figure | 35.1Cash and equivalents, Q3 FY2024, at 2024-09-30$35.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 33.2Cash and equivalents, FY2024, at 2024-12-31$33.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-115878.Report this figure | 21.1Cash and equivalents, Q1 FY2025, at 2025-03-31$21.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | 20.6Cash and equivalents, Q2 FY2025, at 2025-06-30$20.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 90.1Cash and equivalents, Q3 FY2025, at 2025-09-30$90.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 85.4Cash and equivalents, FY2025, at 2025-12-31$85.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 178Cash and equivalents, Q1 FY2026, at 2026-03-31$177.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 92.7Cash and equivalents, Q2 FY2026, at 2026-06-30$92.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Current assets | $m | 98.5Current assets, Q3 FY2023, at 2023-09-30$98.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063517.Report this figure | 90.2Current assets, FY2023, at 2023-12-31$90.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043925.Report this figure | 231Current assets, Q1 FY2024, at 2024-03-31$231.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056965.Report this figure | 231Current assets, Q2 FY2024, at 2024-06-30$231.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093733.Report this figure | 213Current assets, Q3 FY2024, at 2024-09-30$213.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 195Current assets, FY2024, at 2024-12-31$195.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115878.Report this figure | 165Current assets, Q1 FY2025, at 2025-03-31$165.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | 146Current assets, Q2 FY2025, at 2025-06-30$145.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 183Current assets, Q3 FY2025, at 2025-09-30$183.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 142Current assets, FY2025, at 2025-12-31$142.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 205Current assets, Q1 FY2026, at 2026-03-31$205.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 161Current assets, Q2 FY2026, at 2026-06-30$160.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Total assets | $m | 104Total assets, Q3 FY2023, at 2023-09-30$104.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0000950170-23-063517.Report this figure | 95.9Total assets, FY2023, at 2023-12-31$95.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0000950170-25-043925.Report this figure | 248Total assets, Q1 FY2024, at 2024-03-31$248.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056965.Report this figure | 237Total assets, Q2 FY2024, at 2024-06-30$237.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093733.Report this figure | 219Total assets, Q3 FY2024, at 2024-09-30$219.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 200Total assets, FY2024, at 2024-12-31$200.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-115878.Report this figure | 170Total assets, Q1 FY2025, at 2025-03-31$170.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | 150Total assets, Q2 FY2025, at 2025-06-30$150.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 187Total assets, Q3 FY2025, at 2025-09-30$187.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 146Total assets, FY2025, at 2025-12-31$145.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 209Total assets, Q1 FY2026, at 2026-03-31$208.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 165Total assets, Q2 FY2026, at 2026-06-30$165.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Current liabilities | $m | 6.6Current liabilities, Q3 FY2023, at 2023-09-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063517.Report this figure | 9.5Current liabilities, FY2023, at 2023-12-31$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043925.Report this figure | 12.8Current liabilities, Q1 FY2024, at 2024-03-31$12.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056965.Report this figure | 21.2Current liabilities, Q2 FY2024, at 2024-06-30$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093733.Report this figure | 16.3Current liabilities, Q3 FY2024, at 2024-09-30$16.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 24.4Current liabilities, FY2024, at 2024-12-31$24.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115878.Report this figure | 22.1Current liabilities, Q1 FY2025, at 2025-03-31$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | 26.6Current liabilities, Q2 FY2025, at 2025-06-30$26.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 45.1Current liabilities, Q3 FY2025, at 2025-09-30$45.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 64.8Current liabilities, FY2025, at 2025-12-31$64.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 47.8Current liabilities, Q1 FY2026, at 2026-03-31$47.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 34.2Current liabilities, Q2 FY2026, at 2026-06-30$34.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Total liabilities | $m | 11.2Total liabilities, Q3 FY2023, at 2023-09-30$11.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0000950170-23-063517.Report this figure | 14.2Total liabilities, FY2023, at 2023-12-31$14.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0000950170-25-043925.Report this figure | 17.4Total liabilities, Q1 FY2024, at 2024-03-31$17.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056965.Report this figure | 25.8Total liabilities, Q2 FY2024, at 2024-06-30$25.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093733.Report this figure | 20.6Total liabilities, Q3 FY2024, at 2024-09-30$20.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 28.4Total liabilities, FY2024, at 2024-12-31$28.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-115878.Report this figure | 25.9Total liabilities, Q1 FY2025, at 2025-03-31$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | 30.1Total liabilities, Q2 FY2025, at 2025-06-30$30.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108797.Report this figure | 48.3Total liabilities, Q3 FY2025, at 2025-09-30$48.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 67.8Total liabilities, FY2025, at 2025-12-31$67.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 50.5Total liabilities, Q1 FY2026, at 2026-03-31$50.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 37.9Total liabilities, Q2 FY2026, at 2026-06-30$37.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | 92.7Shareholders' equity, Q3 FY2023, at 2023-09-30$92.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-30, accession 0000950170-24-119100.Report this figure | 81.7Shareholders' equity, FY2023, at 2023-12-31$81.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-115878.Report this figure | 231Shareholders' equity, Q1 FY2024, at 2024-03-31$230.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 211Shareholders' equity, Q2 FY2024, at 2024-06-30$211.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 198Shareholders' equity, Q3 FY2024, at 2024-09-30$198.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 172Shareholders' equity, FY2024, at 2024-12-31$171.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 144Shareholders' equity, Q1 FY2025, at 2025-03-31$144.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 120Shareholders' equity, Q2 FY2025, at 2025-06-30$119.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 139Shareholders' equity, Q3 FY2025, at 2025-09-30$139.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266969.Report this figure | 78.1Shareholders' equity, FY2025, at 2025-12-31$78.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 158Shareholders' equity, Q1 FY2026, at 2026-03-31$158.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure | 127Shareholders' equity, Q2 FY2026, at 2026-06-30$127.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331529.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (9.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0000950170-24-119100. Derived: 9-month figure less the 6-month figure.Report this figure | (9.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0000950170-25-043925. Derived: 12-month figure less the 9-month figure.Report this figure | (10.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-30, accession 0000950170-25-061222.Report this figure | (14.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108797. Derived: 6-month figure less the 3-month figure.Report this figure | (24.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$24.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0000950170-24-119100. Derived: 9-month figure less the 6-month figure.Report this figure | (21.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | (26.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$26.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | (19.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-331529. Derived: 6-month figure less the 3-month figure.Report this figure | not reported | not reported | (44.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$44.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | (44.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$44.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-331529. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | 0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266969. Derived: 9-month figure less the 6-month figure.Report this figure | 0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$179.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$49.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224087.Report this figure | 0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-331529. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266969. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115878. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported |
Shares
| Line item | Unit | Q1 FY20222022-03-31 | Q2 FY20222022-06-30 | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 18.3 | 18.3 | 22.2 | 43.9 | 43.9 | 43.9 | 53.6 | 63.8 | 63.8 | 64.0 | 64.0 | 78.3 |
Shares outstanding: 103.88m at Aug 2, 2026, from the cover of the 10-Q filed Aug 4, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.